Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,546,760
+$3,017,078 QoQ
Shares Held
430,315
+210.8% QoQ
Ownership
0.513%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 99.79085088830276.ToString("F0")%
Shared 0.ToString("F0")%
None 0.20914911169724504.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. EYPT ranks #94 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in EYPT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,546,760 | 430,315 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,529,682 | 138,461 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,555,168 | 179,436 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,545,462 | 376,776 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,755,321 | 323,860 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,636,957 | 353,954 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,651,845 | 457,052 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,223,497 | 600,402 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,168,076 | 104,890 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,461,462 | 149,782 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $556,343 | 69,630 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $160,597 | 54,625 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $265,657 | 75,902 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $101,445 | 12,825 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $106,732 | 13,562 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $236,390 | 19,456 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,362,503 | 193,015 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $412,414 | 40,592 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||